Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced maculopathy.

Mahmood J Khan1, Thanos Papakostas1, Kyle Kovacs1

  • 1Department of Ophthalmology, Weill Cornell Medical College, New York, New York.

Current Opinion in Ophthalmology
|October 1, 2020
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Tonabersat Connexin-43 Modulator for Diabetic Macular Edema with Good Vision (DRCR Retina Network Protocol AN).

Ophthalmology science·2026
Same author

Retinal Imaging Findings in Patients with Maturity-Onset Diabetes of the Young.

Ophthalmology science·2025
Same author

Adverse Events Associated with Devices for Incisional Glaucoma Surgery Performed with Implants as Reported to the FDA MAUDE Database.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie·2025
Same author

Multimodal Imaging of a Unique Transitory Finding in Ocular Syphilis.

Journal of vitreoretinal diseases·2024
Same author

Harnessing the power of longitudinal medical imaging for eye disease prognosis using Transformer-based sequence modeling.

ArXiv·2024
Same author

PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING.

Retina (Philadelphia, Pa.)·2024

This review details drug-induced maculopathies, covering their symptoms, diagnosis, and treatments. It highlights common maculopathies like pigmentary changes and macular edema to aid retina specialists.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Toxicology

Background:

  • Drug-induced maculopathies are an increasing concern.
  • Retina specialists need updated information on ocular side effects.

Purpose of the Study:

  • To review drug-induced maculopathies.
  • To cover clinical presentations, diagnostic findings, and treatments.
  • To inform retina specialists of relevant drug side effects.

Main Methods:

  • Literature review of drug-induced maculopathies.
  • Analysis of pathophysiologic mechanisms.
  • Synthesis of clinical presentations and treatment options.

Main Results:

  • Identified drugs causing pigmentary and crystalline maculopathy.

Related Experiment Videos

  • Documented photoreceptor dysfunction, cystoid macular edema, and central serous choroidopathy.
  • Reviewed drug-induced uveitis and vascular damage.

    • Conclusions:

    • Updated findings on drug-induced maculopathies are presented.
    • Pathophysiologic mechanisms, presentations, and treatments are discussed.
    • Provides essential knowledge for clinical practice.